THPO and hepatocellular carcinoma: Conversely, enhanced activity of the VEGF-A/VEGFR-2 ligand/receptor complex in the context of HCC, by other still-unknown oxygen-independent mechanisms, may increase THPO expression by malignant hepatocytes, triggering a positive autocrine feedback loop that augments pro-tumorigenic signal propagation.